Product image of Neurotop Retard (Carbamazepine) supplied by GNH India

Neurotop Retard

Active Ingredient:
Carbamazepine
Origin:
EU

Neurotop Retard (Carbamazepine)

Carbamazepine, the active ingredient in Neurotop Retard, is an anticonvulsant presented as an extended‑release tablet for oral use. It is employed to treat various seizure types, neuropathic facial pain, and mood stabilization in bipolar disorder in adult patients and children when indicated. It is manufactured according to EU Good Manufacturing Practice standards.

GNH India supplies Neurotop Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance globally.

Manufacturer / TM Owner

G.L. Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Carbamazepine is used to manage seizure disorders and certain neuropathic pain and mood disorders by modulating neuronal activity.

  • Partial seizures: reduces frequency and severity of focal seizure episodes in patients with epilepsy.
  • Generalized tonic‑clonic seizures: helps control convulsive seizures and decrease recurrence.
  • Trigeminal neuralgia: alleviates intense facial pain attacks associated with this neuropathic condition.
  • Bipolar disorder: stabilizes mood and prevents manic episodes in adults.

How It Works

  • Carbamazepine blocks voltage‑gated sodium channels in neuronal membranes, preferentially binding to the inactivated state. This stabilizes hyperexcited neurons, limits repetitive firing, and diminishes synaptic transmission. The drug also exerts secondary effects on calcium channels and may modulate glutamate release, contributing to its anticonvulsant and analgesic properties. Additionally, carbamazepine enhances GABAergic inhibition indirectly and reduces excitatory neurotransmitter release, overall contributing to seizure control.

Side Effects

Carbamazepine may cause a range of adverse reactions, from mild to potentially serious.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Drowsiness: increased sleepiness or fatigue.
  • Nausea: upset stomach, sometimes accompanied by vomiting.
  • Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects

  • Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement.
  • Aplastic anemia: bone‑marrow failure leading to low blood cell counts.
  • Hepatotoxicity: liver injury manifested by jaundice, elevated enzymes or hepatic failure.

Precautions & Warnings

When prescribing carbamazepine, clinicians should consider several safety precautions to minimize risks.

  • Pregnancy: category D; use only if benefits outweigh potential fetal risks.
  • Hepatic impairment: monitor liver function tests and adjust dose as needed.
  • Blood disorders: perform regular complete blood count to detect agranulocytosis or aplastic anemia.
  • Drug interactions: review concomitant medications for potential pharmacokinetic or pharmacodynamic effects.
  • Renal impairment: use with caution; assess renal function periodically.
  • Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Avoid Interactions

Carbamazepine interacts with several medicines, requiring dose adjustments or avoidance.

Major Interactions (Avoid)

  • Erythromycin: may increase carbamazepine plasma concentrations, raising toxicity risk.
  • Azole antifungals (e.g., ketoconazole): can elevate carbamazepine levels and precipitate adverse effects.
  • Rifampicin: induces metabolism, markedly reducing carbamazepine concentrations and efficacy.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: carbamazepine may decrease hormonal effectiveness; consider alternative contraception.
  • Valproic acid: combined use can increase risk of hepatic toxicity and other adverse events.
  • Serotonergic agents: may enhance central nervous system depression; monitor for excessive sedation.

Frequently Asked Questions

Neurotop Retard contains carbamazepine, which is prescribed for partial (focal) seizures, generalized tonic‑clonic seizures, trigeminal neuralgia—a painful facial nerve disorder—and for mood stabilization in adults with bipolar disorder.

Carbamazepine blocks voltage‑gated sodium channels on neurons, especially when they are in an inactivated state. This reduces repetitive firing, stabilizes hyperexcited membranes, and limits synaptic transmission, thereby decreasing seizure activity and neuropathic pain signals.

The appropriate dose of Neurotop Retard is individualized by the prescribing clinician based on the patient’s age, weight, renal and hepatic function, seizure type, and response to therapy. No fixed regimen is provided here.

Carbamazepine is classified as pregnancy category D, indicating evidence of risk to the fetus. It should be used only when the potential benefit justifies the risk. Limited data exist for breastfeeding; clinicians should weigh benefits against possible infant exposure.

To request Neurotop Retard, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other anticonvulsants, carbamazepine offers strong efficacy for focal seizures and trigeminal neuralgia but may have more drug‑interaction potential due to enzyme induction. Alternatives such as levetiracetam have fewer interactions but different efficacy profiles for specific seizure types.

Neurotop Retard should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and ensure the container is tightly closed.

Neurotop Retard is taken orally, usually once daily due to its extended‑release formulation. Tablets should be swallowed whole with water and not crushed, chewed, or split, to maintain the intended release profile.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, blood disorders like aplastic anemia or agranulocytosis, and liver toxicity (hepatitis or hepatic failure). Prompt medical attention is required if symptoms such as rash, fever, jaundice, or unexplained fatigue develop.

Neurotop Retard is contraindicated in patients with known hypersensitivity to carbamazepine or other iminostilbene derivatives, in individuals with bone‑marrow depression, and in patients taking monoamine oxidase inhibitors within 14 days. Caution is also advised for those with severe hepatic or renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Carbamazepine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT